Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization and Validation of Electric Acoustic Stimulation (EAS) Mapping as a Function of Residual Hearing After CI-Implantation

NCT07476079 is registered in ClinicalTrials.gov with Luzerner Kantonsspital as lead sponsor.

NCT NCT07476079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07476079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization and Validation of Electric Acoustic Stimulation (EAS) Mapping as a Function of Residual Hearing After CI-Implantation
Lead sponsor
Luzerner Kantonsspital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
November 1, 2027
Enrollment
12 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

fitting methods by eas patients